Bone marrow mesenchymal stem cells are abnormal in multiple myeloma
- PMID: 17344918
- PMCID: PMC2346535
- DOI: 10.1038/sj.leu.2404621
Bone marrow mesenchymal stem cells are abnormal in multiple myeloma
Abstract
Recent literature suggested that cells of the microenvironment of tumors could be abnormal as well. To address this hypothesis in multiple myeloma (MM), we studied bone marrow mesenchymal stem cells (BMMSCs), the only long-lived cells of the bone marrow microenvironment, by gene expression profiling and phenotypic and functional studies in three groups of individuals: patients with MM, patients with monoclonal gamopathy of undefined significance (MGUS) and healthy age-matched subjects. Gene expression profile independently classified the BMMSCs of these individuals in a normal and in an MM group. MGUS BMMSCs were interspersed between these two groups. Among the 145 distinct genes differentially expressed in MM and normal BMMSCs, 46% may account for a tumor-microenvironment cross-talk. Known soluble factors implicated in MM pathophysiologic features (i.e. IL (interleukin)-6, DKK1) were revealed and new ones were found which are involved in angiogenesis, osteogenic differentiation or tumor growth. In particular, GDF15 was found to induce dose-dependent growth of MOLP-6, a stromal cell-dependent myeloma cell line. Functionally, MM BMMSCs induced an overgrowth of MOLP-6, and their capacity to differentiate into an osteoblastic lineage was impaired. Thus, MM BMMSCs are abnormal and could create a very efficient niche to support the survival and proliferation of the myeloma cells.
Figures










Similar articles
-
Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.PLoS One. 2013;8(3):e59756. doi: 10.1371/journal.pone.0059756. Epub 2013 Mar 21. PLoS One. 2013. PMID: 23555770 Free PMC article.
-
Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.Cancer Res. 2012 Mar 15;72(6):1395-406. doi: 10.1158/0008-5472.CAN-11-0188. Epub 2012 Feb 2. Cancer Res. 2012. PMID: 22301101
-
Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.Cancer Biol Ther. 2014 Oct;15(10):1413-22. doi: 10.4161/cbt.29924. Epub 2014 Jul 21. Cancer Biol Ther. 2014. PMID: 25046247 Free PMC article.
-
[The Latest Research Progress of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients --Review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1233-1236. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.047. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37551504 Review. Chinese.
-
The osteoblastic niche in the context of multiple myeloma.Ann N Y Acad Sci. 2015 Jan;1335:45-62. doi: 10.1111/nyas.12578. Epub 2014 Nov 25. Ann N Y Acad Sci. 2015. PMID: 25424768 Review.
Cited by
-
Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?Blood Cancer J. 2012 Sep 14;2(9):e91. doi: 10.1038/bcj.2012.38. Blood Cancer J. 2012. PMID: 22983434 Free PMC article.
-
Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.PLoS One. 2013;8(3):e59756. doi: 10.1371/journal.pone.0059756. Epub 2013 Mar 21. PLoS One. 2013. PMID: 23555770 Free PMC article.
-
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.Int J Mol Sci. 2022 Dec 7;23(24):15448. doi: 10.3390/ijms232415448. Int J Mol Sci. 2022. PMID: 36555090 Free PMC article. Review.
-
Mesenchymal Stem Cells Inhibit the Effects of Dexamethasone in Multiple Myeloma Cells.Stem Cells Int. 2022 Apr 4;2022:4855517. doi: 10.1155/2022/4855517. eCollection 2022. Stem Cells Int. 2022. PMID: 35419059 Free PMC article.
-
Bone Marrow Microenvironment in Light-Chain Amyloidosis: In Vitro Expansion and Characterization of Mesenchymal Stromal Cells.Biomedicines. 2021 Oct 22;9(11):1523. doi: 10.3390/biomedicines9111523. Biomedicines. 2021. PMID: 34829752 Free PMC article.
References
-
- Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature. 2001;411:375–379. - PubMed
-
- Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci. 2004;117:1495–1502. - PubMed
-
- Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17–32. - PubMed
-
- Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med. 1996;335:91–97. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical